Clinical factors in prediction of prognosis after anterior resection with total mesorectal excision for carcinoma of the rectum

Oncology Reports

Volumn 17, Issue 2, 2007, Pages 471-475

  Szynglarewicz, Bartlomiej ^a   Matkowski, Rafal ^a   Forgacz, Jozef ^a   Pudelko, Marek ^a   Smorag, Zbigniew ^a   Dryl, Jacek ^a   Kornafel, Jan ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Anterior resection; Carcinoembryonic antigen; Prognostic factors; Rectal cancer; Total mesorectal excision

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECTUM TUMOR; RECURRENT DISEASE; RISK; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RECURRENCE; RISK; TREATMENT OUTCOME;

EID: 33947728828     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.2.471     Document Type: Article

References (44)

1. Boyle P and Leon ME: Epidemiology of colorectal cancer. Br Med Bull 64: 1-25, 2002. (Pubitemid 35238576)
2. Heald RJ, Husband EM and Ryall RDH: The mesorectum in rectal cancer surgery - the clue to the pelvic recurrence. Br J Surg 69: 613-616, 1982. (Pubitemid 12038080)
3. Minsky BD: Adjuvant therapy of resectable rectal cancer. Cancer Treat Rev 28: 181-188, 2002.
4. Glimelius BL: The role of preoperative and postoperative radiotherapy in rectal cancer. Clin Colorectal Cancer 2: 82-92, 2002.
5. + cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10: 309-323, 2003.
6. Abdalla SA, Behzad F, Bsharah S, Kumar S, Amini SK, O'Dwyer ST and Habowbi NY: Prognostic relevance of microvessel density in colorectal tumours. Oncol Rep 6: 839-842, 1999.
7. Cerottini JP, Caplin S, Pampallona S and Givel JC: Prognostic factors in colorectal cancer. Oncol Rep 6: 409-414, 1999.
8. Chang S.C, Lin JK, Lin TC and Liang WY: Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Int J Oncol 26: 65-75, 2005.
9. Cunningham MP, Essapen S, Thomas H, Green M, Lovell DP, Topham C, Marks C and Modjtadehi H: Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer. Int J Oncol 27: 317-325, 2005.
10. Essapen S, Thomas H, Green M, De Vries C, Cook MG, Marks C, Topham C and Modjtadehi H: The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters. Int J Oncol 24: 241-248, 2004.
11. Hiranuma C, Kawakami K, Oyama K, Ota N, Omura K and Watanabe G: Hypermethylation of the MYOD 1 gene is a novel prognostic factor in colorectal cancer. Int J Mol Med 13: 413-417, 2004.
12. Sogawa N, Takiguchi N, Koda K, Oda K, Satomi D, Kato K, Ishigura H and Miyazaki M: Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer treated with preoperative radiochemotherapy. Int J Oncol 21: 787-793, 2002.
13. Aoki T, Katsumata K, Tsuchida A, Tomioka H and Kayanagi Y: Correlation between malignancy grade and p53 gene in relation to thymidine phosphorylase activity in colorectal cancer patients. Oncol Rep 9: 1267-1271, 2002.
14. Yoshikawa R, Yanagi H, Kusunoki M, Fujiwara Y, Noda M, Hashimoto-Tamaoki T and Yamamura T: Prognostic value of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients. Int J Oncol 21: 1223-1228, 2002.
15. Deans GT, Parks TG, Rowlands BJ and Spence RAJ: Prognostic factors in colorectal cancer. Br J Surg 79: 608-613, 1992.
16. Hansen HJ, Snyder JJ, Miller E, van de Voorde JP, Miller ON, Hines LR and Burns JJ: Carcinoembryonic antigen (CEA) assay: a laboratory adjunct in the diagnosis and management of cancer. Hum Pathol 5: 139-147, 1974.
17. Gold P and Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467-481, 1965.
18. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K and Stanners CP: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334, 1989. (Pubitemid 19112371)
19. Thompson JA, Grunert F and Zimmermann W: Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5: 344-366, 1991.
20. Bendardaf R, Lamlum H and Pyrhonen S: Prognostic and predictive molecular markers in colorectal carcinoma. Anticancer Res 24: 2519-2530, 2004. (Pubitemid 39166341)
21. Horig H, Medina FA, Conkright WA and Kaufman HL: Strategies for cancer therapy using carcinoembryonic antigen (CEA) vaccines. Exp Rev Mol Med 1462: 1-24, 2000.
22. Kattlove H and Winn RJ: Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 54: 172-196, 2003. (Pubitemid 36722308)
23. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK and Oettgen HF: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299: 448-451, 1978. (Pubitemid 9011330)
24. Hohenberger W, Bittorf B, Papadopoulos T and Merkel S: Survival after surgical treatment of cancer of the rectum. Langenbecks Arch Surg 390: 363-372, 2005. (Pubitemid 41253167)
25. Kim JC, Lee KH, Yu CS, Kim HC, Kim JR, Chang HM, Kim JH, Kim JS and Kim TW: The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer. Eur J Surg Oncol 30: 271-279, 2004. (Pubitemid 38425644)
26. Behbehani AI, Al-Sayer H, Farghaly M, Kanawati N, Mathew A, Al-Bader A and Van Dalen A: Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait. Int J Biol Markers 15: 51-55, 2000. (Pubitemid 30195483)
27. Turoldo A, Balani A, Scaramucci M, Pistan V, Roseano M and Liguori G: Preoperative CEA: prognostic significance in colorectal carcinoma. Tumori 89 (Suppl 4): 95-97, 2003.
28. Louhimo J, Carpelan-Holmstrom M, Alfthan H, Stenman UH, Jarvinen HJ and Haglund C: Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 101: 545-548, 2002.
29. Park YJ, Park KJ, Park JG, Lee KU, Choe KJ and Kim JP: Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 23: 721-726, 1999. (Pubitemid 29314417)
30. Harrison LE, Guillem JG, Paty P and Cohen AM: Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 185: 55-59, 1997. (Pubitemid 27276742)
31. Chen CC, Yang SH, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS and Chang SC: Is it reasonable to add preoperative serum level of CEA and CA 19-9 to staging for colorectal cancer? J Surg Res 124: 169-174, 2005.
32. Wang WS, Chen PM, Chiou TJ, Liu JH, Fan FS, Lin TC, Jiang JK, Yang SH, Yen CC, Wang HS and Lin JK: Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan. Hepatogastroenterology 47: 1590-1594, 2000.
33. Bannura G, Cumsille MA, Contreras J, Melo C, Barrera A, Reinero M and Pardo L: Prognostic factors in colorectal neoplasm. Multivariate analysis in 224 patients. Rev Med Chil 129: 237-246, 2001.
34. Moertel CG, O'Fallon JR, Go VLW, O'Connell MJ and Thynne GS: The preoperative carcinoembryonic antigen test in diagnosis, staging and prognosis of colorectal cancer. Cancer 58: 603-610, 1986. (Pubitemid 16072059)
35. Steele GJr, Ellenberg S, Ramming K, O'Connell M, Moerlet C, Lessner H, Bruckner H, Horton J, Schein P, Zamcheck N, Novak J and Holyoke ED: Carcinoembryonic antigen monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg 196: 162-169, 1982.
36. Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CL, Lin TC, Jieng JK, Yang SH, Wang HS and Chen PM: Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol 30: 12-16, 2000.
37. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH and Eu KW: High preoperative serum carcinoembryonic antigen predict metastatic recurrence in potentially curative colonic cancer: results of a five-year study. Dis Colon Rectum 44: 231-235, 2001. (Pubitemid 32173772)
38. Cecil TD, Sexton R, Moran BJ and Heald RJ: Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 47: 1145-1150, 2004.
39. Hermanek P and Heald RJ: Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal? Colorectal Dis 6: 10-14, 2004. (Pubitemid 38195485)
40. Kane JM III and Petrelli NJ: Controversies in the surgical management of rectal cancer. Semin Radiat Oncol 13: 403-418, 2003.
41. Colquhoun P, Wexner SD and Cohen A: Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision. J Surg Oncol 83: 133-139, 2003. (Pubitemid 36807940)
42. Obrink B: CEA adhesion molecules: multifunctional proteins with signal regulatory properties. Curr Opin Cell Biol 9: 616-626, 1997.
43. Von Kleist S, Miguel I, Halla B: Possible function of CEA as cell-contact inhibitory molecule. Anticancer Res 15: 1889-1894, 1995. (Pubitemid 26031257)
44. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RG, Nielsen ML, Sargent DJ, Taylor CR, Welton M and Willet C: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 979-994, 2000. (Pubitemid 30602039)